With the combined goal of finding the best anti-parasitic and anti-cancer activities as well as isolating the bioactive agents and studying their structures and biological properties, we proceeded to perform a small-scale cultivation of Aspergillus sp. strain F1544 using Potato Dextrose, Malt Extract, Czapek Dox and Eight Vegetables media. From the more promising extracts (obtaining using potato dextrose and czapek dox media in large scale) of this fungus, we isolated the five compounds: pseurotin A (1), 14-norpseurotin A (2), FD-838 (3), and pseurotin D (4), and fumoquinone B (5). All compounds showed good antileishmanial and moderate anticancer activities.
BennettJW. (2010) “An overview of the genus Aspergillus”. In Aspergillus: Molecular Biology and Genomics. MachidaM, GomiK. (Eds). Caister Academic Press, NorfolkUK. 1–17;
2.
TobertJA. (2003) Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors. Nature Reviews Drug Discovery, 2, 517–526;
3.
ChangRS, LottiVJ, MonaghanRL, BirnbaumJ, StapleyEO, GoetzMA, Albers-SchönbergG, PatchettAA, LieschJM, HensensOD, SpringerJP. (1985) A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus. Science, 230, 177–179;
4.
OleynekJJ, SedlockDM, BarrowCJ, AppellKC, CasianoF, HaycockD, WardSJ, KaplitaP, GillumAM. (1994) WIN 64821, a novel neurokinin antagonist produced by an Aspergillus sp. II. Biological activity. The Journal of Antibiotics, 47, 399–410.
BlochP, TammC, BollingerP, PetcherTJ, WeberHP. (1976) Pseurotin, a new metabolite of Pseudeurotium ovalis STOLK having an unusual hetero-spirocyclic system. Helvetica Chimica Acta, 59, 133–137;
7.
WeberHP, PetcherTJ, BlochP, TammC. (1976) The crystal and molecular structure of 12, 13-dibromopseurotin. Helvetica Chimica Acta, 59, 137–140;
8.
GeHM, YuZG, ZhangJ, WuJH, TanRX. (2009) Bioactive alkaloids from endophytic Aspergillus fumigatus. Journal of Natural Products, 72, 753–755;
9.
MizoueK, OkazakiT, HanadaK, AmamotoT, YamagishiM, OmuraS. (1987) Physiologically active substance FD-838 and process for preparing the same. European Patent Application, EP 216607, JP Appl. 205278;
10.
BreitensteinW, ChexalKK, MohrP, TammC. (1981) Pseurotin B, C, D, and E. Further new metabolites of Pseudeurotium ovalis STOLK. Helvetica Chimica Acta, 64, 379–388;
11.
IshikawaM, NinomiyaT, AkabaneH, KushidaN, TsujiuchiG, OhyamaM, GomiS, ShitoK, MurataT. (2009) Pseurotin A and its analogues as inhibitors of immunoglobuline E production. Bioorganic & Medicinal Chemistry Letters, 19, 1457–1460.
12.
HayashiA, FujiokaS, NukinaM, KawanoT, ShimadaA, KimuraY. (2007) Fumiquinones A and B, nematicidal quinones produced by Aspergillus fumigatus. Bioscience, Biotechnology, and Biochemistry, 71, 1697–1702.
13.
CalderonA, RomeroLI, Ortega-BarriaE, BrunR, CorreaMA, GuptaMP. (2006) Evaluation of larvicidal and in vitro antiparasitic activities of plants in a biodiversity plot in the Altos de Campana National Park, Panama. Pharmaceutical Biology, 44, 487–498.
14.
CorbettY, HerreraL, GonzalezJ, CubillaL, CapsonTL, ColeyPD, KursarTA, RomeroLI, Ortega-BarriaE. (2004) A novel DNA-based microfluorimetric method to evaluate antimalarial drug activity. American Journal of Tropical Medicine and Hygiene, 70, 119–124.
15.
BucknerFS, VerlindeCL, La FlammeAC, Van VoorhisWC. (1996) Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase. Antimicrobial Agents and Chemotherapy, 40, 2592–2597.
16.
MonksA, ScudieroD, SkehanP, ShoemakerR, PaulK, VisticaD, HoseC, LangleyJ, CroniseP, Vaigro-WolffA, Gray-GoodrichM, CampbellH, MayoJ, BoydM. (1991) Feasibility of a high-flux anticancer drug screening using a diverse panel of cultured human tumor cell lines. Journal of the National Cancer Institute, 83, 757–766.
